Ab
−ves ). To investigate effects of ascertainment bias the following 48 periods were studied: up to one year before (pre-HCV) / within one year 49 of (peri-HCV) / more than one year post (post-HCV) the date of 50 HCV-diagnosis. 51 T2DM had been diagnosed in 2.9% of Ab +ves (including 3.2% of 52 RNA +ves and 2.3% of RNA -ves ) and 2.7% of Ab compared to without, either current HCV-infection (OR, 1.1; 95% CI, 82 0.6-1.9) or with current or past HCV-infection (OR, 1.0; 95% CI, 83 0.6-1.7). In addition, a large population based cohort study from 84
Southern Italy showed that compared to HCV −ve controls only people 85 with HCV and elevated alanine aminotransferase (ALT) levels were at 86 higher odds of developing T2DM (OR,1.5; 95% CI, 1.0-2.2), while 87 those with HCV and normal baseline ALT levels were at lower odds 88 (OR, 0.6; 95% CI, 0.3-1.1) (10). Another study of people enrolled in a 89 community-based cohort in the US showed that HCV infection 90 increased the risk of developing diabetes (adjusted hazard ratio (HR), 91 11.6; 95%CI 1.4-96.6), but only among those at high risk of diabetes 92 (based on body mass index and age) (11). Finally, a recent meta analysis 93 suggested, on the basis of limited evidence, that having diabetes can also 94 be a risk factor for contracting HCV (12) . 95
The heterogeneity of findings from the different studies indicates 96 that, at a population level, the effect of HCV on T2DM risk is 97 comparably low and varies between different strata of the population. 98
Therefore, studies to estimate the size of the effect of HCV on T2DM in 99 the general population need to be sufficiently large to allow examination 100 of different strata of the population and need careful control of 101 Generalized linear mixed models (R, package lme4) were used for 224 the analysis of the odds of T2DM diagnosis pre-HCV and peri-HCV. 225
Mixed effects Cox models (R, package coxme) were used for the 226 analysis of the hazard of T2DM diagnosis post-HCV. In all three 227 regression models, the year of HCV diagnosis (grouped into prior to 228 229 groups using the original quintiles: 1-2=high, 3=medium and 4-5=low 230 deprivation) and age at HCV diagnosis were included as explanatory 231 variables. Fractional polynomials were used to model age at HCV 232 diagnosis (R, package mfp). To adjust for correlation within matched 233 groups, a random group effect was added to all three models. 234
To study if the estimated effect of HCV-infection on the probability 235 of T2DM diagnosis was modified by period of HCV diagnosis, sex, 236 social deprivation or age at HCV diagnosis, interaction-terms between 237 these variables and HCV were added to the full model. Likelihood ratio 238 tests were used for testing the statistical significance of interaction terms 239 and those interaction terms that were not statistically significant 240 
Results

255
Characteristics of the study population 256 Table 1 and who lived in areas with high or low deprivation; however, due to the 375 small sample size, those differences were not statistically significant 376 (Table 5) . 377 of HCV infection on the risk of diabetes diagnosis in the elderly, both 496 our HCV infected cohort is still s were too relatively young (median age 497 at HCV infection diagnosis was 33 years), and the followed -up for a 498 period (median of 6.45 years) too short, and thus the excess risk of 499 T2DM may still change as our cohort advances in age and duration of 500 infection. 501
Male sex and living in areas of highest deprivation decreased effects 502 of HCV infection on the risk of T2DM diagnosis. This effect 503 modification was not related to follow-up time, age at HCV-infection or 504 RNA-status since those did not differ within sex and social deprivation. 505
Since male sex and high deprivation are positively related to T2DM risk, 506 our observation does not confirm the suggestion from (11) that relative 507 effects of HCV on T2DM risk are higher in people at increased risk of 508 T2DM. However, the effect modification could be explained by 509 different uptake of health care (and thereby testing for diabetes) in men 510 living in areas of high deprivation. The effect modification could explain 511 some of the heterogeneity that both meta analyses found, since few of 512 the reviewed studies stratified by sex and none by social deprivation. 513
However, widely accepted biological models of the effects of HCV 514 infection on T2DM risk (5-7) do not explain the observed effect 515 modification. Moreover, while sex, social deprivation and year of birth 516 were included in our matched analysis to increase efficiency of the study 517 (30), the analysis of effect modification by sex, social deprivation, year 518 and age was purely exploratory. were unknown to us, the temporal relationship of onset of HCV infection 534 and T2DM is not known. Indeed, T2DM has been described as a risk 535 factor for contracting HCV (12). However, an estimated 86% of 536 HCV-infection in Scotland is related to injecting drug use (31) and a 537 large fraction of those diagnosed HCV-positive will have been infected 538 in their early drug using career. Given that the risk of developing T2DM 539 increases with age, it is unlikely that the increased risk for HCV in those 540 with T2DM was responsible for the results of our study. 541
Our study has demonstrated that on the population level the size of 542 the effect of HCV antibody status on T2DM is smaller than effects of 543 many life style choices (e.g., obesity, smoking and alcohol consumption) 544 and therefore not as significant a public health concern as previously 545 suggested from predominantly clinic based studies. cohort, interaction-terms other than sex × HCV were deemed not statistically significant and therefore excluded from the final model. 3 Adjusted OR and P for exposure to HCV-infection within strata of sex. Odds ratios adjusted for age at HCV diagnosis, year of HCV diagnosis, social deprivation and the extra correlation due to the matching. 4 Synergy Index. 
